Oncology CDMOs

Synergy Innovation Inc. is a US-based company that leverages technology to transform manufacturing processes, providing high-speed assembly lines and non-destructive inspection systems. No website is available and search results do not indicate pharmaceutical drug manufacturing. The company appears to be an equipment/technology supplier rather than a CDMO.

Taizhou Crene Biotechnology is a Chinese company specializing in the manufacture of APIs and pharmaceutical intermediates, located in the Taizhou API production base (largest in China). Products include prostaglandins, kinase inhibitors (PARP, PI3K, FAK, AKT, CDK, VEGFR, c-Met), veterinary APIs, and custom synthesis. They have a GMP production base and offer custom synthesis services. The company has a 3,600 m2 facility. They primarily supply APIs and intermediates rather than finished drug products.

Greek advanced biotechnology company focused on cell and gene therapy (CDMO activity). Subsidiary/partner of Orgenesis Inc. Designated as a priority investment in Greece in collaboration with Orgenesis. Aims to make advanced therapies accessible and affordable. Recognized as a top precision medicine solution company in Europe. Note: website has SSL certificate error and is inaccessible, so information is primarily from search results and SEC filings indicating CDMO activity for cell/tissue-based therapies.

uBriGene Biosciences Inc is the same entity as uBriGene (duplicate entry, different ID). This is the China-headquartered entity of the same global CRDMO providing one-stop viral vector-based CDMO services for research and clinical applications. Series C+ funding of 150M CNY (~$20M USD). Same website, same capabilities. See uBriGene entry (ID 10a6a05c) for full details.

Corning Incorporated (Life Sciences & Pharmaceutical Technologies)

India

Corning Incorporated's Pharmaceutical Technologies division manufactures advanced glass packaging solutions for the pharmaceutical industry, most notably Valor Glass vials and containers designed for drug storage and delivery. The company is a materials science and glass technology company, not a drug manufacturer or CDMO.

EMA Pharmaceuticals (Ema Pharma)

France

EMA Pharmaceuticals (Ema Pharma) is a French manufacturer of overseals (crimping capsules) for injectable pharmaceutical applications. The company specializes in sealing solutions for vials used in pharmaceutical injectable products, manufactured in a GMP-compliant facility. Note: The FDA regulatory data (90 approved products, 184 recalls) appears to be associated with a different entity sharing the FEI registrations, not the French crimp cap manufacturer.

Flagship Biotech International is an Indian pharmaceutical company headquartered in Mumbai with manufacturing facilities across India (Tarapur, Navsari, Naroda, Baddi). It manufactures a broad range of pharmaceutical dosage forms including tablets, capsules, injectables, LVP, SVP, inhalers, ointments, and suppositories for its own brands and contract manufacturing for organizations globally in 45+ countries.

Flow Eighteen38 is a protein sciences division within the FairJourney Biologics Group, based in Portugal, providing antibody characterization, protein production, and biophysical analysis services. It received 5 million euros to expand production and biophysical capabilities, serving the drug discovery and research community.

Genuone Sciences Inc. is a South Korean pharmaceutical CDMO valued at approximately $752 million, offering specialized contract development and manufacturing services including formulation development through finished product production. The company provides pharmaceutical manufacturing and analytical services for both domestic and international clients. Genuone is 100% owned by IMM Private Equity.

GSA Medical INC. is a US-based product development and manufacturing company focused on rapid immunoassay diagnostic products. The company's corporate mission is to provide quality rapid immunoassay products; it does not appear to provide pharmaceutical contract manufacturing services.

HEC (HEC Pharm / Sunshine Lake Pharma)

China

HEC Pharm (also known as Sunshine Lake Pharma or Guangdong HEC Pharma) is a Chinese integrated pharmaceutical company established in 2003, focused on drug R&D, production, and commercialization of innovative drugs, generics, and biosimilars. The company specializes in anti-infection (oseltamivir) and chronic disease therapeutic areas with over 6,000 employees and 100+ R&D projects.

Kekule Pharma Limited

India

Kekule Pharma Limited is a Hyderabad-based API and pharmaceutical intermediates manufacturer in India. Specializes in developing novel (patent non-infringing) processes for API synthesis. Offers custom synthesis, contract manufacturing, scale-up from kgs to tons, impurity synthesis, and regulatory documentation (DMFs in CTD format). Extensive product portfolio including oncology APIs (Capecitabine, Temozolomide, Imatinib, Gefitinib, Bortezomib), CNS (Escitalopram, Citalopram), GI (Pantoprazole, Famotidine), and others. FDA registered with 2 FEI numbers, 3 inspections (3 VAI).

Mac-Chem Products (India) Pvt. Ltd.

India

Mac-Chem Products (India) Pvt. Ltd., part of the NMM Group (Naprod), is a pharmaceutical API manufacturer specializing in Oncology, General APIs, and Bulk Sterile products. They have manufacturing plants in four locations employing around 800 professionals. Naprod (parent) is a pioneer in lyophilization with an ultra-modern manufacturing facility. They hold multiple international regulatory approvals including USFDA, EDQM, COFEPRIS, ANVISA, MFDS-Korea, and WHO-GMP/ISO certifications.

Indian pharmaceutical CDMO specializing in pre-finished formulation intermediates (PFI) and finished dosage forms (FDF). Manufactures oral solids, oral liquids, injectables, ophthalmics, topicals, and inhalation products. Strong focus on pellet technology and nanotechnology-based drug delivery systems. CRAMS (Contract Research and Manufacturing Services) provider.

Nanjing Sino Pharmaceutical Ltd.

China

Chinese pharmaceutical company specializing in production, R&D, and export of generic medicines globally. Covers 1,000+ products across antibiotic, antimalarial, analgesic-antipyretic, cardiovascular, respiratory, antiviral/anti-cancer, hormone, and other therapeutic categories. 20+ years of international registration and export experience in dozens of countries. FDA registered with 3 FEI numbers.

NEON LABORATORIES LTD

India

Indian pharmaceutical company (established 1984) that emerged as a leader in anesthesia and critical care products. Manufactures 500+ products sold in 70+ markets. Multi-located manufacturing facilities including API and formulations. Started as contract manufacturer for anesthesia products (1992) and grew into branded generics. Major plant at Palghar with 460 million units capacity. Has dedicated manufacturing units for cephalosporins and oncology to avoid cross-contamination. 2000+ employees. FDA registered with 3 FEI numbers, 29 inspections (13 NAI, 15 VAI, 1 OAI). Began API production in 2008. Also has medical devices division (HOSPRO).

RNP Pharmachem is an Indian pharmaceutical company providing CDMO/CMO services and site transfer project activities. The company operates a Singapore EU-GMP approved manufacturing facility and has 51-200 employees. Limited information is available about the company's specific capabilities and therapeutic focus beyond its general CDMO/CMO service offering.

SteriMax Inc.

Canada

SteriMax Inc. is a family-owned Canadian specialty pharmaceutical company based in Oakville, Ontario. They develop, source, manufacture, market, and distribute essential hospital and retail pharmacy products to the Canadian healthcare market. Their portfolio includes generic and branded products across sterile injectables, oral solids, and other essential products. SteriMax has a Health Canada-approved QC lab and their products are manufactured in Health Canada, FDA, or EMEA approved facilities. While they have some internal pharmaceutical manufacturing capabilities (their website mentions production and manufacturing), their primary model appears to be sourcing, marketing, and distributing pharmaceutical products in Canada rather than offering contract manufacturing services to third parties. They are not positioned as a CDMO/CMO.

Sumitomo (SHI) Demag

Germany

Sumitomo (SHI) Demag Plastics Machinery GmbH manufactures injection moulding machines (all-electric, hydraulic, and hybrid types) for the plastics industry with over 125,000 machines installed globally. While the company serves pharmaceutical packaging and medical device applications, it does not manufacture drugs or pharmaceutical products.

Kaneka Eurogentec (part of Kaneka Group, Japan) is a Belgian CDMO established in 1985, FDA inspected, GMP accredited. Manufactures starting materials and APIs for clinical and commercial phases. Core products: GMP plasmid DNA (gram to kg scale), GMP recombinant proteins and antibody fragments, GMP mRNA (50g per batch, commercial-ready facility accredited June 2025), GMP oligonucleotides (pre-clinical and Phase 1/2), GMP conjugates. Also supplies research-grade oligonucleotides and diagnostic tools. 475 employees. FDA registered with 2 FEI numbers, 7 inspections (1 NAI, 6 VAI). Plasmid DNA serves as starting material for viral vector and mRNA production.

Just - Evotec Biologics (wholly owned by Evotec) is a biologics CDMO specializing in monoclonal antibodies, next-generation biologics, and biosimilar products. Differentiated by proprietary integrated end-to-end continuous manufacturing platform (J.POD) which uses perfusion cell culture with continuous purification, achieving higher output in smaller footprint than traditional batch manufacturing. Two manufacturing sites in Seattle and Redmond, WA. Offers cell line development, analytical services, process development, and early clinical through commercial cGMP manufacturing. Uses AI/ML technologies in development.

Mycenax Biotech is a Taiwan-based biologics CDMO specializing in the development and manufacturing of biosimilars, monoclonal antibodies, bispecific antibodies, ADCs, and cell & gene therapy-related products. The company provides integrated services spanning cell line development, process development, analytical services, GMP manufacturing, and regulatory support for global biotech and pharmaceutical partners. With expertise in mammalian cell culture and biologics manufacturing, Mycenax supports clients from early-stage development through commercial-scale production. The company has established GMP facilities in Taiwan and focuses on delivering flexible, high-quality manufacturing solutions for complex biologics and next-generation therapeutics.

Pharma-Bio Serv (assumed)

Puerto Rico

PharmaBioServ is a consulting firm founded in 1993 in Puerto Rico that provides integrated quality and compliance services to highly regulated manufacturers worldwide. Services include cGMP consulting, commissioning/qualification/validation, and regulatory compliance support across pharmaceuticals, biotechnology, advanced therapies, medical devices, and food industries.

Pharmatech Labs

United States

Pharmatech Labs, based in Lindon, Utah, is a nutritional contract manufacturer of liquid and powder supplements. The company provides turnkey services including concept development, R&D, customization, flavor work, in-house laboratories, quality manufacturing, packaging, kitting, and low-cost fulfillment & storage. Product formats include pouches, stick packs, gusseted bags, capsules, canisters, liquids, blister packs, and oils. This is a nutraceutical/dietary supplement manufacturer, NOT a pharmaceutical CDMO -- no evidence of drug manufacturing, FDA drug registration, or pharmaceutical GMP compliance was found.

Jiangsu Hengrui Medicine Co., Ltd. is China's largest listed pharmaceutical company, founded in 1970, with over 20,000 employees globally. Hengrui is primarily an innovation-driven pharma company developing and manufacturing its own drugs across oncology, cardiovascular, metabolism, autoimmune, pain, and anti-infection therapeutic areas, with a pipeline of 257 drugs and 24 Class 1 innovative drugs. While it has some CDMO references in search results, Perplexity research confirms it primarily specializes in proprietary drug development and manufacturing rather than contract services.

Spectrum Chemical Manufacturing Corp, headquartered in New Brunswick, New Jersey, is an FDA-registered supplier of high-purity chemicals, APIs, excipients, fine chemicals, intermediates, nutrients for formulated media, and cGMP chemicals for biopharmaceutical and life science industries. They offer over 45,000 chemicals including the largest catalog of 1,200 USP-NF-FCC items, with bicoastal manufacturing facilities in New Jersey and California. While listed on CDMO directories, Spectrum's core business is manufacturing and distributing chemical raw materials and lab supplies rather than contract drug product manufacturing for other companies.

Sun Pharmaceutical Industries Ltd. (Sun Pharma) is one of the world's largest specialty generic pharmaceutical companies, headquartered in Mumbai, India. While the company has massive manufacturing operations (1,075 FDA-approved products, 25+ FDA-registered FEI numbers), it primarily manufactures and markets its own branded and generic pharmaceutical products rather than providing contract manufacturing services to third parties as a CDMO.

Allsino Pharmaceutical is a Chinese pharmaceutical company. No website content was available for detailed extraction. The company name suggests pharmaceutical manufacturing, but without evidence, capabilities cannot be assigned beyond the classification.

Taisho Pharmaceutical Holdings is a major Japanese pharmaceutical company, not a CDMO. The company operates across domestic self-medication (OTC products including the well-known Pabron cold medicine brand), international business, and prescription pharmaceutical operations. They have multiple production facilities in Japan and FDA-registered sites. With 10 clinical trials and therapeutic focus areas in nephrology and oncology, Taisho is an integrated pharma company manufacturing its own branded products, not offering contract manufacturing services.